Cancer Prevention Research CR Magazine 2010 Workshops
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Prevention Research 1, 285, September 1, 2008. doi: 10.1158/1940-6207.CAPR-08-0012
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kassie, F.
Right arrow Articles by Hecht, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kassie, F.
Right arrow Articles by Hecht, S. S.

Research Articles

Combinations of N-Acetyl-S-(N-2-Phenethylthiocarbamoyl)-L-Cysteine and myo-Inositol Inhibit Tobacco Carcinogen–Induced Lung Adenocarcinoma in Mice

Fekadu Kassie, Ilze Matise, Mesfin Negia, David Lahti, Yunqian Pan, Robyn Scherber, Pramod Upadhyaya and Stephen S. Hecht

Authors' Affiliation: University of Minnesota Cancer Center, Minneapolis, Minnesota

Requests for reprints: Fekadu Kassie, University of Minnesota Cancer Center, Mayo Mail Code 806, 420 Delaware Street Southeast, Minneapolis, MN 55455. Phone: 612-626-5143; Fax: 612-626-5135; E-mail: kassi012{at}umn.edu.


We have previously generated convincing evidence that combinations of N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine (PEITC-NAC; 3 µmol/g diet) and myo-inositol (MI; 56 µmol/g diet) were significantly more effective than the individual compounds as inhibitors of tobacco smoke carcinogen–induced lung tumorigenesis in A/J mice. In this study, we further investigated the efficacy of combinations of PEITC-NAC (9 or 15 µmol/g diet) and MI (56 µmol/g diet). Female A/J mice were treated with a mixture of the tobacco smoke carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene by gavage once weekly for 8 weeks. PEITC-NAC plus MI was given in the diet beginning at 1 day after the 4th of eight carcinogen treatments (temporal sequence A) or 1 week after the last carcinogen treatment (temporal sequence B). Regardless of the dose of carcinogen or PEITC-NAC plus MI, or temporal sequence, administration of PEITC-NAC plus MI significantly reduced the multiplicity of gross tumors and, in most instances, adenocarcinoma. PEITC-NAC plus MI was particularly effective against bigger tumors. The observed inhibition of lung tumorigenesis by PEITC-NAC plus MI was attributed, at least partly, to inhibition of cell proliferation and induction of apoptosis. These results clearly show the efficacy of PEITC-NAC plus MI in the prevention of tobacco carcinogen–induced lung adenocarcinoma in A/J mice and provide a basis for future evaluation of PEITC-NAC plus MI in clinical trials as a chemopreventive agent for current and former smokers.

Key Words: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone • benzo[a]pyrene • lung tumorigenesis • chemoprevention • N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine • myo-inositol




This article has been cited by other articles:


Home page
CarcinogenesisHome page
F. Kassie, S. Kalscheuer, I. Matise, L. Ma, T. Melkamu, P. Upadhyaya, and S. S. Hecht
Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice
Carcinogenesis, February 1, 2010; 31(2): 239 - 245.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. M. Memmott and P. A. Dennis
The Role of the Akt/mTOR Pathway in Tobacco Carcinogen-Induced Lung Tumorigenesis
Clin. Cancer Res., January 1, 2010; 16(1): 4 - 10.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.